The International Journal of Endocrinology and Metabolism is a leading peer-reviewed publication dedicated to advancing knowledge and research in the fields of endocrinology, diabetes, and metabolism. Published by BRIEFLAND in the Netherlands, this journal features original research, comprehensive reviews, and insightful clinical studies that explore the multifaceted aspects of hormonal disorders and metabolic conditions. With an impact factor that places it in the Q3 quartile category for 2023, the journal serves as a critical resource for academics and practitioners aiming to stay at the forefront of this dynamic field. Spanning from 2010 to 2024, the journal offers an enriching platform for innovative ideas and practices, fostering collaboration among scholars and healthcare professionals alike. Although not open access, the content is meticulously curated to ensure high-quality scientific discourse, positioning the International Journal of Endocrinology and Metabolism as an essential reference for those dedicated to improving health outcomes related to endocrine and metabolic disorders.

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

EUROPEAN JOURNAL OF ENDOCRINOLOGY, published by Oxford University Press, stands as a premier international platform dedicated to advancing research in the burgeoning field of endocrinology, diabetes, and metabolism. Since its inception in 1994, this esteemed journal has gained recognition for its rigorous peer-reviewed articles and innovative studies, evidenced by its impressive Q1 rankings across multiple categories, including Endocrinology and Medicine. With a focus on disseminating critical findings and fostering interdisciplinary collaboration, the journal ranks 33rd out of 244 in Endocrinology, Diabetes, and Metabolism, and 20th out of 128 in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics, positioning it in the top percentiles for researchers worldwide. Although it does not offer open access, the journal remains a vital resource for academics and practitioners alike who seek to stay at the forefront of endocrine research. The EUROPEAN JOURNAL OF ENDOCRINOLOGY continues to push the boundaries of knowledge, driving forward the understanding of complex hormonal functions and their clinical implications.

Journal of Endocrinology Metabolism and Diabetes of South Africa, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital platform for advancing research and knowledge dissemination in the fields of endocrinology, metabolism, and diabetes. Since its transition to Open Access in 2012, it has enabled greater accessibility to crucial findings and data, broadening its reach to researchers, practitioners, and students alike. Though its coverage in Scopus was discontinued in 2018, the journal continues to play an important role in fostering discourse in the medical community, as evidenced by its ranking within the 19th and 16th percentiles for Internal Medicine and Endocrinology, diabetes and metabolism, respectively. With its commitment to addressing pressing health issues in South Africa and beyond, this journal remains an invaluable resource for those seeking to understand and tackle the complexities of metabolic diseases.

Diabetes & Metabolic Syndrome-Clinical Research & Reviews is a leading peer-reviewed journal published by ELSEVIER SCI LTD in the field of endocrinology, diabetes, and internal medicine. With an impressive impact factor evidenced by its high rankings, this journal is positioned in the top quartile (Q1) across multiple categories, including Endocrinology, Diabetes and Metabolism, and Internal Medicine. Spanning from 2007 to 2024, it serves as a vital resource for researchers, healthcare professionals, and students alike, offering comprehensive reviews and innovative clinical research related to metabolic disorders. Located in the Netherlands, the journal emphasizes an open-access approach, ensuring valuable insights are available to a global audience. By publishing high-quality and impactful articles, Diabetes & Metabolic Syndrome not only contributes to the advancement of scientific knowledge but also plays a crucial role in shaping clinical practices and enhancing patient care in the realm of diabetes and metabolic syndrome.

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.